You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美食品及藥物管理局指接種強生疫苗致出現吉巴氏症風險增加
阿思達克 07-13 14:56
美國食品及藥物管理局致函強生(JNJ.US),指數據顯示接種強生新冠疫苗六週後,出現罕見神經系統疾病的風險增加。

當局指接種後出現吉巴氏綜合症的機會非常低,但強生疫苗接種者如出現刺痛感、走路困難或面部表情難以控制,便應尋求醫生意見。強生發表聲明稱,正與監管當局商討有關個案,又指出現吉巴氏綜合症的比率,小幅度高於沒有接種下出現的比率。

美國有1,280萬人接種一劑性強生新冠疫苗,當局至今接獲100宗出現吉巴氏綜合症的初步報告,當中95宗爲嚴重個案並須入院,且有1宗死亡病例。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account